
China’s Pharmaceutical Breakthroughs Go Global: Behind the $45 Billion Boom and the Next Great Test
China’s Pharmaceutical Innovation Goes Global: Challenges and New Momentum In the first five months of…

China’s Pharmaceutical Innovation Goes Global: Challenges and New Momentum In the first five months of…

On May 6, the U.S. government announced plans to unveil new pharmaceutical tariff measures within…

In the first half of 2025, China’s innovative drug license-out deals surpassed USD 15 billion,…

In an increasingly interconnected pharmaceutical landscape, the role of a reliable China drug import and…

Guangdong, China — May 22, 2025 丨 The National Medical Products Administration (NMPA) has officially…

On July 3, 2025, Simcere Pharmaceutical Group Limited’s innovative drug subsidiary, Simcere, announced that its…

Recently, the National Medical Products Administration (NMPA) granted conditional approval for Olgotrelvir Sodium Capsules, a…

The National Medical Products Administration (NMPA) has officially approved Firsekibart Injection, a Class 1 innovative…

With the rapid globalization of China’s pharmaceutical industry, the question of how China ensures the…

For international importers and healthcare distributors, learning how to verify authenticity of Chinese medicines has…